In terms of market taxonomy for Oxyhydrogen Inhalation Machine types, the market splits into Proton Exchange Membrane (PEM) systems and Electrolysis-based units. PEM systems, comprising 65% of the market, are preferred for their compact design and high efficiency, ideal for hospital settings. Electrolysis-based units account for 35%, offering lower maintenance costs but requiring more space, making them suitable for large research facilities. The type-specific adoption reflects trade-offs between operational efficiency, infrastructure compatibility, and cost. This segmentation directly impacts market growth trajectories, with PEM systems driving expansion in clinical segments due to their scalability.